Apolipoprotein A-I enhances activated protein C cytoprotective activity
Open Access
- 8 June 2020
- journal article
- research article
- Published by American Society of Hematology in Blood Advances
- Vol. 4 (11), 2404-2408
- https://doi.org/10.1182/bloodadvances.2019001316
Abstract
Key Points. High-density lipoprotein and apolipoprotein A-I enhance activated protein C cytoprotective activity.High-density lipoprotein and apolipoprotein A-IKeywords
This publication has 20 references indexed in Scilit:
- PAR1 biased signaling is required for activated protein C in vivo benefits in sepsis and strokeBlood, 2018
- The Immunoregulatory Activities of Activated Protein C in Inflammatory DiseaseSeminars in Thrombosis and Hemostasis, 2017
- A novel protein C-factor VII chimera provides new insights into the structural requirements for cytoprotective protease-activated receptor 1 signalingJournal of Thrombosis and Haemostasis, 2017
- Activated protein C β-glycoform promotes enhanced noncanonical PAR1 proteolysis and superior resistance to ischemic injuryBlood, 2015
- Biased agonism of protease-activated receptor 1 by activated protein C caused by noncanonical cleavage at Arg46Blood, 2012
- Activated protein C targets CD8+ dendritic cells to reduce the mortality of endotoxemia in miceJCI Insight, 2010
- The efficacy of activated protein C in murine endotoxemia is dependent on integrin CD11bJCI Insight, 2010
- The ligand occupancy of endothelial protein C receptor switches the protease-activated receptor 1-dependent signaling specificity of thrombin from a permeability-enhancing to a barrier-protective response in endothelial cellsBlood, 2007
- Endothelial barrier protection by activated protein C through PAR1-dependent sphingosine 1–phosphate receptor-1 crossactivationBlood, 2005
- Activation of Endothelial Cell Protease Activated Receptor 1 by the Protein C PathwayScience, 2002